Wouter Peelaerts

1.9k total citations · 1 hit paper
17 papers, 1.4k citations indexed

About

Wouter Peelaerts is a scholar working on Neurology, Neurology and Physiology. According to data from OpenAlex, Wouter Peelaerts has authored 17 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Neurology, 10 papers in Neurology and 8 papers in Physiology. Recurrent topics in Wouter Peelaerts's work include Parkinson's Disease Mechanisms and Treatments (13 papers), Alzheimer's disease research and treatments (8 papers) and Neurological diseases and metabolism (6 papers). Wouter Peelaerts is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (13 papers), Alzheimer's disease research and treatments (8 papers) and Neurological diseases and metabolism (6 papers). Wouter Peelaerts collaborates with scholars based in Belgium, United States and France. Wouter Peelaerts's co-authors include Veerle Baekelandt, Ronald Melki, Luc Bousset, Anke Van der Perren, Chris Van den Haute, Michèle Giugliano, Anastasiya Moskalyuk, Rocco Pulizzi, Patrik Brundin and Géraldine Gelders and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Brain.

In The Last Decade

Wouter Peelaerts

16 papers receiving 1.4k citations

Hit Papers

α-Synuclein strains cause distinct synucleinopathies afte... 2015 2026 2018 2022 2015 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wouter Peelaerts Belgium 10 1.1k 595 399 375 340 17 1.4k
Nishant N. Vaikath Qatar 17 974 0.9× 427 0.7× 269 0.7× 339 0.9× 267 0.8× 30 1.3k
Nour K. Majbour Qatar 21 1.5k 1.4× 668 1.1× 390 1.0× 538 1.4× 312 0.9× 36 1.9k
Amanda L. Woerman United States 17 988 0.9× 757 1.3× 584 1.5× 376 1.0× 744 2.2× 35 1.7k
Anastasiya Moskalyuk Belgium 6 690 0.6× 408 0.7× 244 0.6× 313 0.8× 273 0.8× 10 995
Rocco Pulizzi Belgium 4 690 0.6× 407 0.7× 242 0.6× 293 0.8× 259 0.8× 5 976
Zachary A. Sorrentino United States 18 740 0.7× 559 0.9× 290 0.7× 320 0.9× 276 0.8× 43 1.1k
Charles L. Graves United States 4 761 0.7× 641 1.1× 239 0.6× 293 0.8× 276 0.8× 6 1.1k
Shiji Varghese Australia 10 809 0.7× 446 0.7× 175 0.4× 214 0.6× 148 0.4× 17 1.0k
Noriko Ishigami Japan 11 542 0.5× 448 0.8× 189 0.5× 211 0.6× 243 0.7× 13 976
Mark S. Moehle United States 17 1.1k 1.0× 399 0.7× 492 1.2× 568 1.5× 610 1.8× 27 1.7k

Countries citing papers authored by Wouter Peelaerts

Since Specialization
Citations

This map shows the geographic impact of Wouter Peelaerts's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wouter Peelaerts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wouter Peelaerts more than expected).

Fields of papers citing papers by Wouter Peelaerts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wouter Peelaerts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wouter Peelaerts. The network helps show where Wouter Peelaerts may publish in the future.

Co-authorship network of co-authors of Wouter Peelaerts

This figure shows the co-authorship network connecting the top 25 collaborators of Wouter Peelaerts. A scholar is included among the top collaborators of Wouter Peelaerts based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wouter Peelaerts. Wouter Peelaerts is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Mercado, Gabriela, et al.. (2024). Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications. Journal of Parkinson s Disease. 14(7). 1301–1329. 2 indexed citations
3.
Mercado, Gabriela, Dieter Plessers, Jennifer A. Steiner, et al.. (2024). Chronic urinary tract infections cause persistent microglial changes in a humanized ɑ-synuclein mouse model. Journal of Parkinson s Disease. 14(8). 1559–1574. 1 indexed citations
4.
Peelaerts, Wouter & Veerle Baekelandt. (2023). ⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans. Neurotherapeutics. 20(1). 67–82. 9 indexed citations
5.
Perren, Anke Van der, Audrey Coens, Géraldine Gelders, et al.. (2022). Host oligodendrogliopathy and α-synuclein strains dictate disease severity in multiple system atrophy. Brain. 146(1). 237–251. 13 indexed citations
6.
George, Sonia, Trevor Tyson, Nolwen L. Rey, et al.. (2021). T Cells Limit Accumulation of Aggregate Pathology Following Intrastriatal Injection of α-Synuclein Fibrils. Journal of Parkinson s Disease. 11(2). 585–603. 18 indexed citations
8.
Marmion, David J., Wouter Peelaerts, & Jeffrey H. Kordower. (2021). A historical review of multiple system atrophy with a critical appraisal of cellular and animal models. Journal of Neural Transmission. 128(10). 1507–1527. 11 indexed citations
9.
Peelaerts, Wouter, Sonia George, Michaela Johnson, et al.. (2020). Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits. SHILAP Revista de lepidopterología. 1. 33–33. 4 indexed citations
10.
Perren, Anke Van der, Géraldine Gelders, Alexis Fenyi, et al.. (2020). The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies. Acta Neuropathologica. 139(6). 977–1000. 171 indexed citations
11.
Mercado, Gabriela, et al.. (2019). Can infections trigger alpha-synucleinopathies?. Progress in molecular biology and translational science. 168. 299–322. 56 indexed citations
12.
Quansah, Emmanuel, Wouter Peelaerts, J. William Langston, et al.. (2018). Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration. Molecular Neurodegeneration. 13(1). 28–28. 57 indexed citations
13.
Peelaerts, Wouter, Luc Bousset, Veerle Baekelandt, & Ronald Melki. (2018). ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences. Cell and Tissue Research. 373(1). 195–212. 96 indexed citations
14.
Peelaerts, Wouter & Tiago F. Outeiro. (2017). Disease-Modifying Targets in Neurodegenerative Disorders. 5 indexed citations
15.
Peelaerts, Wouter & Veerle Baekelandt. (2016). α-synuclein folds: the cards are on the table. Nature Structural & Molecular Biology. 23(5). 359–360. 7 indexed citations
16.
Peelaerts, Wouter & Veerle Baekelandt. (2016). ɑ‐Synuclein strains and the variable pathologies of synucleinopathies. Journal of Neurochemistry. 139(S1). 256–274. 67 indexed citations
17.
Peelaerts, Wouter, Luc Bousset, Anke Van der Perren, et al.. (2015). α-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 522(7556). 340–344. 877 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026